- Home
- CDNA vs SDHC Comparison
CDNA vs SDHC Comparison
Compare CDNA & SDHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- SDHC
- Stock Information
- Founded
- CDNA 1998
- SDHC 2008
- Country
- CDNA United States
- SDHC United States
- Employees
- CDNA N/A
- SDHC N/A
- Industry
- CDNA Medical Specialities
- SDHC
- Sector
- CDNA Health Care
- SDHC
- Exchange
- CDNA Nasdaq
- SDHC Nasdaq
- Market Cap
- CDNA 1.1B
- SDHC 1.2B
- IPO Year
- CDNA 2014
- SDHC 2024
- Fundamental
- Price
- CDNA $18.92
- SDHC $20.49
- Analyst Decision
- CDNA Buy
- SDHC Hold
- Analyst Count
- CDNA 8
- SDHC 5
- Target Price
- CDNA $29.43
- SDHC $29.60
- AVG Volume (30 Days)
- CDNA 912.4K
- SDHC 82.8K
- Earning Date
- CDNA 05-08-2025
- SDHC 03-12-2025
- Dividend Yield
- CDNA N/A
- SDHC N/A
- EPS Growth
- CDNA N/A
- SDHC N/A
- EPS
- CDNA 0.93
- SDHC 1.81
- Revenue
- CDNA $333,785,000.00
- SDHC $975,463,000.00
- Revenue This Year
- CDNA $13.32
- SDHC $27.24
- Revenue Next Year
- CDNA $14.99
- SDHC $9.97
- P/E Ratio
- CDNA $20.44
- SDHC $11.67
- Revenue Growth
- CDNA 19.07
- SDHC 27.57
- 52 Week Low
- CDNA $7.42
- SDHC $19.52
- 52 Week High
- CDNA $34.84
- SDHC $39.50
- Technical
- Relative Strength Index (RSI)
- CDNA 36.93
- SDHC 40.10
- Support Level
- CDNA $17.73
- SDHC $19.52
- Resistance Level
- CDNA $22.61
- SDHC $22.37
- Average True Range (ATR)
- CDNA 1.31
- SDHC 1.44
- MACD
- CDNA -0.35
- SDHC 0.05
- Stochastic Oscillator
- CDNA 18.97
- SDHC 31.64
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
About SDHC Smith Douglas Homes Corp.
Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. The company has organized into five geographical segments so their reportable segments include Atlanta, Raleigh, Charlotte, Nashville, and Alabama which consists of both Birmingham and Huntsville.